Article | Open | Published:

# Longevity defined as top 10% survivors and beyond is transmitted as a quantitative genetic trait

## Abstract

Survival to extreme ages clusters within families. However, identifying genetic loci conferring longevity and low morbidity in such longevous families is challenging. There is debate concerning the survival percentile that best isolates the genetic component in longevity. Here, we use three-generational mortality data from two large datasets, UPDB (US) and LINKS (Netherlands). We study 20,360 unselected families containing index persons, their parents, siblings, spouses, and children, comprising 314,819 individuals. Our analyses provide strong evidence that longevity is transmitted as a quantitative genetic trait among survivors up to the top 10% of their birth cohort. We subsequently show a survival advantage, mounting to 31%, for individuals with top 10% surviving first and second-degree relatives in both databases and across generations, even in the presence of non-longevous parents. To guide future genetic studies, we suggest to base case selection on top 10% survivors of their birth cohort with equally long-lived family members.

## Introduction

Human lifespan has a low heritability (12–25%)1,2,3,4, whereas survival into extreme ages (longevity) clusters within families5,6,7,8,9. Studies showed that parents, siblings5,6,7,9,10,11,12, and children7,13,14,15,16,17 of longevous persons lived longer than first-degree relatives of non-longevous persons or population controls. In addition, members of these longevous families seem to delay or even escape age-related diseases18,19,20,21 and in fact, healthy ageing in such families is marked by well attuned immune systems and good metabolic health22,23,24. Understanding the genetic factors influencing longevity may provide novel insights into the mechanisms that promote health and minimize disease risk1,25. Identifying longevity loci, however, has been challenging and only a handful of genetic variants have been shown to associate with longevity across multiple independent studies25,26,27,28,29,30,31,32. The most consistent evidence has been obtained for variants in APOE and FOXO3A genes25,26,27,28,29,30,33 in either genome-wide association studies (GWAS) or candidate gene studies.

The lack of consistent findings in longevity studies hampers comparative research and may be explained by genetic and environmental heterogeneity on one hand and uncertainty in defining the longevity trait itself, as illustrated by the large variation of longevity definitions on the other hand1,3,7,10,13,14,15,16,17,19,20,25,26,27,28,29,30,31,32,34,35,36,37,38. Establishing a threshold that best isolates the genetic component of longevity and including mortality information of family members is important because the environmentally-related increase in lifespan over recent decennia has caused an increase in longevity phenocopies. As a result, genetic longevity studies generally focus on singletons (i.e., individuals without longevous family members), selected based on one generation of mortality data27,28,31,32,39. Here, we aim to establish the threshold for longevity in unselected (for survival) multigenerational families and determine the importance of longevous family members for case selection so that those insights can be used in genetic studies to identify novel longevity loci.

We use the data available in the Utah Population Database (UPDB, Utah) and the LINKing System for historical family reconstruction (LINKS, Zeeland) based on US and Dutch citizens, respectively. Zeeland was a region with difficult living conditions compared to Utah (see Methods section). In these datasets, we identify 20,360 three-generational families (F1–F3) containing index persons (IPs, F2), their parents (F1), siblings (F2), spouses (F2), and children (F3) comprising 314,819 persons in total. First, we examine the association between the survival, measured as age at death, of IPs (F2) and the number of parents (F1) and siblings (F2) belonging to the top 1–60% of their birth cohort, in a cumulative way (comparing mutually inclusive percentile groups). Second, we determine the survival percentile threshold that drives the cumulative effects as a criterion for defining human longevity by investigating IP (F2) survival when divided into mutually exclusive groups based on the longevity of their parents (F1) and siblings (F2). Third, we focus on the top 10% parents and siblings to investigate whether longevous and non-longevous parents, with increasing number of longevous siblings, transmit longevity to the IPs. Fourth, we confirm our findings in the next generation (F3) by examining the association between the survival, measured as age at death or last observation, of IPs’ children (F3) and longevity of IPs (F2), their spouses (parents, F2) and siblings (aunts and uncles, F2). Finally, we explore potential environmental influences by studying spouses (F2) of longevous IPs (F2).

## Results

### Study population

We identified three generations of families in the UPDB and LINKS covering 10,246 and 10,114 families, respectively, who were centered around a single IP (F2) per family (Fig. 1). We identified parents (F1, NUPDB = 20,492 and NLINKS = 20,228), siblings (F2, NUPDB = 54,144 and NLINKS = 53,978), spouses (F2, NUPDB = 11,230 and NLINKS = 10,788), and children (F3, NUPDB = 61,104 and NLINKS = 62,495) for all IPs in both datasets (Table 1). IPs were born between 1767 and 1902 in the UPDB, and between 1797 and 1902 in LINKS. In the UPDB, 51% of the IPs were female, compared to 53% in LINKS. The IPs’ mean age at death was 70.88 (SD = 16.03) years in the UPDB and 63.86 (SD = 17.99) years in LINKS. No IPs were censored, as they were selected to have an available birth and death date. In addition, Supplementary Figure 1 shows the age at death distribution for the IPs in both datasets. In the following sections, we explore associations between IP survival and the number of 1–60% surviving parents and siblings in a cumulative analysis and subsequently identify in mutually exclusive IP groups the survival percentile threshold that drives the cumulative effect and demarcates longevity (see Methods section).

### IP survival advantage with top 1–60% parents and siblings

For the first examination of the association between the number of parents (1 or 2, F1) and siblings (1 or 2+, F2) and IP (F2) survival and to explore if a larger level of family aggregation, in terms of numbers of parents (F1) and siblings (F2), was more evident at extreme survival percentiles, we fitted Cox regressions for each subsequent survival percentile (1st to 60th percentile). Figure 2a, c shows that IPs with 1 parent belonging to the top 1–60%, had a survival advantage over IPs without a parent belonging to the top 1–60%. This was shown by the lowest observed statistically significant hazard ratio (HR) of 0.80 (95% CImax-top 1% = 0.73–0.88) in the UPDB and 0.74 (95% CImax-top 1% = 0.65–0.85) in LINKS where max refers to the age with the largest effect and CI to confidence interval. These HRs indicate a 20% and 26% lower hazard of dying respectively and from here we will refer to this as a 20% and 26% survival advantage. Having 2 parents belonging to the top 1–60% provides a stronger survival advantage to IPs (HRmax-top 2%-UPDB = 0.64 (95%CI = 0.50–0.84) and HRmax-top 14%-LINKS = 0.72 (95% CI = 0.65–0.80)), although Fig. 2 shows that the power to detect survival effects of IPs with 2 longevous parents up to the 10th percentile was weak for LINKS due to low group sizes.

The association of IP survival with longevous siblings is shown in Fig. 2b, d. The maximum statistically significant HRs for IPs with 1 longevous sibling were 0.76 (95% CImax-top 1% = 0.62–0.92) and 0.79 (95% CImax-top 5% = 0.67–0.93) in the UPDB and LINKS, respectively. For IPs with 2 or more longevous siblings, these HRs were 0.65 (95% CImax-top 3%-UPDB = 0.51–0.84) and 0.67 (95% CImax-top 8%-LINKS = 0.50–0.90). The slopes in Fig. 2a–d show a slight increase of IP survival advantage with the increase in percentile score. For example, IPs with parents with the best survival (the left-most end of the x-axis) had lower hazard rates than IPs with the least survival (the right-most end of the x-axis). We conclude that IP survival when expressed in HRs, both in the UPDB and LINKS, increased with the number of longevous parents, with the number of longevous siblings and, though modestly, with the increase of parent and sibling survival percentile scores as observed in Fig. 2.

### Top 10–15% surviving family members demarcates longevity

To determine the survival percentile threshold that drove the survival advantage of IPs (F2) with the number of top 1–60% parents (F1), as shown in Fig. 2, we constructed 6 mutually exclusive IP (F2) groups (g) based on the survival percentiles of F1 parents (g1 = [≥0th &  ≤1th percentile], g2 = [≥1th &  ≤5th percentile], g3 = [≥5th &  ≤10th percentile], g4 = [≥10th &  ≤15th percentile], g5 = [≥15th &  ≤20th percentile], g6 = [≥20th &  ≤100th percentile], see Methods section) and compared groups 1–5 with group 6. Figure 3a, b shows the HRs of IP groups for the UPDB and LINKS and is supplemented by the IP age at death and survival percentile variation, as depicted in Supplementary Figure 2. Figure 3a, b illustrates that IPs in groups 1, 2, 3, and 4 had a significant survival advantage compared to group 6, with the lowest HR for group 1 in both the UPDB and LINKS (HRmax-UPDB = 0.76 (95% CI = 0.67–0.86) and HRmax-LINKS = 0.72 (95% CI = 0.60–0.86)). Group 5 did not statistically differ from group 6 (HRgroup5-UPDB = 1 (95% CI = 0.91–1.10) and HRgroup5-LINKS = 0.96 (95% CI = 0.87–1.05)) and thus, these effects indicate that the top 15% surviving parents drove the association with the survival advantage of IPs as shown in Fig. 2.

In the same way, we investigated the association of IPs’ (F2) survival with that of siblings (F2). Figure 3c, d shows a survival advantage of IPs in UPDB group 1–3 and LINKS group 2 and 3 as compared to group 6 with the lowest HR for group 1 (UPDB) and group 2 (LINKS) (HRgroup1-UPDB = 0.70 (95% CI = 0.59–0.85) and HRgroup2-LINKS = 0.77 (95% CI = 0.65–0.92)), respectively. Groups 4 and 5 did not significantly differ from group 6 (HRgroup4-UPDB = 0.99 (95% CI = 0.88–1.12) and HRgroup4-LINKS = 0.86 (95% CI = 0.73–1.02)), which indicated that both in the UPDB and LINKS the top 10% surviving siblings drove the association with the survival advantage of IPs as shown in Fig. 2.

Based on the results presented in the cumulative and mutually exclusive group analyses, we focused on the top 10% surviving family members because the mutually exclusive group analysis (analysis 2, Fig. 3) indicated longevity effects up to the top 10% and 15% for siblings and parents, respectively. Using the top 10% is consistent between the two groups and is a conservative choice. Furthermore, the cumulative analysis (analysis 1, Fig. 2) indicated that the top 10% was a reasonable trade-off between effect size and group size (power) within and between the UPDB and LINKS. Hence, we explored the familial clustering of longevity and the influence of covariates for the top 10% surviving parents and siblings and verified all results in the subsequent generation (F3). Next to the top 10% we also conducted our analyses on the top 5% which are illustrated in Supplementary Figures 35 and Supplementary Tables 15.

### Additive association between 10% surviving relatives and IPs

Figure 2e–h shows the cumulative hazard (CH) curves for IPs (F2) with 0, 1 and 2 or more, or exactly 2 parents/siblings (F1/F2) belonging to the top 10% of their birth cohorts and we show Kaplan–Meier and Nelson–Aalen baseline measures in Supplementary Figure 6. Both in the UPDB and LINKS, the survival advantage associated with the number of top 10% siblings appeared to start during the beginning (45 years in LINKS) and end (65 years in the UPDB) of the mid-life period. In both the UPDB and LINKS, the survival advantage of IPs with the number of top 10% parents started at the age of 40 years. It should be noted that early life effects could not be tested for, because IPs were selected on having a child for the construction of three generation families.

### Survival advantage for children with longevous relatives

We explored the robustness of our findings in F1 and F2 by examining the association between the longevity of IPs (F2), their spouses (F2) and siblings (F2) and the survival of IPs’ children (F3). We investigated whether longevity was transmitted from IPs (F2) to their children (F3) and if the children (F3) with longevous aunts and uncles (siblings of the IPs, F2) had a survival advantage compared to children (F3) without longevous aunts and uncles (F2). To test this, we fitted Cox regressions, with a random effect (frailty) to adjust for within-family relations of the F3 children. Table 3 shows that children of a top 10% surviving IP had a HR of 0.86 (95% CIUPDB = 0.84–0.89) in the UPDB and 0.85 in LINKS (95% CILINKS = 0.82–0.88) compared to children without a top 10% IP. Moreover, results indicated that children with two top 10% parents (IPs and spouses) had a HR of 0.77 (95% CIUPDB = 0.72–0.82) in the UPDB and 0.77 (95% CILINKS = 0.71–0.84) in LINKS. Similar to the IPs, we observed (1) that the survival of children did not depend on maternal or paternal effects (Supplementary Table 9) and (2) that the association between parents and offspring was equal for sons and daughters (Supplementary Table 10).

Children with 1 or more top 10% aunts or uncles had a 4–16% survival advantage compared to children without such aunts or uncles (HRmin-UPDB = 0.96 (95% CI = 0.93–0.99) and HRmax-LINKS = 0.84 (95% CI = 0.78–0.92)), and this effect was independent of having a top 10% parent (either the IP or the IP’s spouse). A stratified analysis showed that the survival benefit for children with the number of top 10% aunts and uncles was still strongly present when the IP and the IP’s spouse were non-longevous (HRmin-UPDB−1 aunt/uncle = 0.96 (95% CI = 0.93–0.99) and HRmax-LINKS−2+ aunts/uncles = 0.81 (95% CI = 0.73–0.90)) (Supplementary Table 11). Lastly, Supplementary Figure 8 shows that the survival benefit for children of a longevous IP and a longevous IP with a longevous spouse (i.e., 1 or 2 longevous parents) started from birth (LINKS) and very early in life (UPDB).

### Spouses live longer in Zeeland but not in Utah

Familial clustering of longevity may depend on (later life) shared environmental effects which could also provide survival benefits to the spouses (F2) of longevous IPs (F2). Hence, we divided the spouses (F2) into mutually exclusive groups according to the survival percentiles of the IPs (see Methods). Figure 4a, c shows that none of the spouse groups in the UPDB differed from reference group 6 or from any of the other groups, indicating no survival benefit for spouses. In LINKS (Fig. 4b, d), spouses of IPs with the highest survival percentile (group 2) had a 14% (HRgroup2-LINKS = 0.86 (95% CI = 0.78–0.94)) survival advantage compared to group 6 spouses. This survival advantage was similar for spouses of IPs in groups 3, 4, and 5 (HRgroup3-LINKS = 0.86 (95% CI = 0.80–0.94); HRgroup4-LINKS = 0.92 (95% CI = 0.85–0.99); HRgroup5-LINKS = 0.86 (95%CI = 0.79–0.93)). For group 1, the effect was comparable but not significant (HRgroup1-LINKS = 0.85 (95% CI = 0.70–1.04)), the test in group 4 did not meet Bonferroni correction for multiple testing.

## Discussion

Human longevity clusters within specific families. Insight into this clustering is important, especially to improve our understanding of genetic and environmental factors driving healthy aging and longevity. The analyses of the UPDB and LINKS datasets, which cover different environmental circumstances, provide strong evidence that for longevous (up to the top 10%) survivors and their families, longevity is transmitted as a quantitative genetic trait, regardless of parental and offspring sex. The main observations supporting this notion are (1) in both datasets the survival of F2 IPs, and their F3 children, increased with each additional longevous parent (F1 and F2) and sibling (F2); (2) in both datasets the survival of IPs (F2) increased with the number of longevous siblings (F2) in the absence of longevous parents (F1) and likewise the survival of IPs’ children (F3) increased with the number of longevous aunts and uncles in the absence of longevous parents. Finally, (3) both datasets indicate an absence of a sex-specific pattern.

Previous studies of smaller sample size than the current study, usually focusing on two generations of selected data (for mortality or geographical locations) identified (1) an increase in the heritability of lifespan with parental age8,40,41 and showed high recurrence risks between parental and offspring or sibling longevity. Thus, providing indications that the heritability of longevity may be stronger than that of lifespan5,7,13,14,42, (2) that sibling relative risks beyond the top 5% survivors might not increase in a linear fashion12 and that this non-linearity may indicate the existence of a longevity threshold43, and (3) longevity recurrence risks for siblings or parents of selected longevous individuals5,6,7,9,10,11,12 and showed increased survival probabilities and longevity recurrence risks for children of longevous parents7,13,14,15,16,17.

Here we used two unique, large three-generational datasets (314,819 individuals in 20,360 families) which were unselected for survival and cover multiple geographical areas. We utilized these datasets to robustly identify a longevity threshold by showing that the association between IP survival and the survival of parents and siblings was not linear but in fact was driven by the oldest, up to the top 10%, surviving parents and siblings. We further showed that the survival of F2 IPs (and their F3 children) increased with each additional longevous parent (F1 and F2), and sibling (F2). We extended these analyses by showing that the survival for children of IPs increased with each additional longevous aunt or uncle. We also extended the analyses by investigating the association between IP survival and sibling longevity, and between the survival of IPs’ children and the longevity of their aunts or uncles in the absence of longevous parents.

Longevity was transmitted even if parents themselves did not become longevous, which supports the notion that a beneficial genetic component was transmitted. Likewise, the identified associations are additive in the sense that an increase in the number of parents, siblings, or aunts and uncles is associated with an increase in the survival of IPs and the children of IPs. This additive pattern is not necessarily expected if the findings are due to other, non-genetic, factors that cluster within families (for example wealth). This evidence is strengthened by the fact that similar additive associations were identified for IPs and children of IPs without longevous parents but with longevous siblings or aunts and uncles (where the latter generally share less environmental influences with the IPs). Further evidence for the transmission of a genetic component was shown by the fact that none of the tested environmental confounders affected the associations between parental/sibling longevity and IP/children survival, as will be discussed further on in the Discussion section. In addition, the fact that we observed very similar results between the two databases, which cover populations with vastly different environmentally-related mortality regimes, significantly adds to the generalizability of our observations regarding the associations between parental/sibling longevity and IP (F2) and children (F3) survival.

We showed that spouses (F2) who married longevous IPs (F2) did not live significantly longer than spouses (F2) who married a non-longevous IP (F2) in the UPDB while they did in LINKS. Previous studies showed inconclusive results regarding a possible survival benefit for spouses of longevous persons6,7,9,44,45. In the Long Life Family study, Pedersen et al.6 identified a survival benefit for spouses of longevous siblings. The authors compared the spouses to sex and birth cohort matched controls and suggest assortative mating as an explanation for the observed survival benefit of the spouses6. A Quebec study, focused on the spouses of 806 centenarians, also reported a survival benefit44 and a study of Southern Italy demonstrated that male nonagenarians outlived their spouses, whereas this was not the case for female nonagenarians45. A recent study showed that the spouses of 944 nonagenarians had no survival benefit but a life-long sustained survival pattern similar to the general population9. An explanation for the difference between the UPDB and LINKS datasets may possibly be that Zeeland had a higher level of relatedness than in Utah. Zeeland had poor living conditions46 and was characterized by out-migration to other provinces or abroad, but limited mobility within the province to other places47. Utah at that time had better living conditions48 with continuous streams of freshly incoming migrants, ensuring a steady influx of new genes49, creating high genetic diversity. Hence, it could be that in Zeeland, spouses and IPs were often related to each other and thus shared some of the genetic component contributing to longevity.

Unlike observations we previously made in the Leiden Longevity Study (LLS)9 concerning maternal effects on longevity in the generation of the nonagenarians and their parents, we did not observe evidence for a stronger transmission from either parent to the IPs (F1 to F2), or from IPs to their children (F2 to F3) in our current study. We cannot draw final conclusions on this aspect because for the F1–F2 transmission we may have missed parental influences on early life mortality since IPs were selected for having survived to an age at which they had one child. However, we did capture early life mortality for F2–F3 but in those generations the selection pressure on child mortality was already slightly decreasing50. In the same way, we observed no differential association between parental longevity and the survival of sons or daughters (F2 and F3). This equal distribution is in line with our observations in the LLS9, but so far, the literature was less conclusive on this point15,16,17.

In all our analyses, except for the spouse analysis, we adjusted for religion (UPDB only), sibship size, birth cohort, sex, socio-economic status, mother’s age at birth, birth order, birth intervals, and twin birth. Some of these biological, social, and demographic factors associated with the mortality of IPs (F2) and their children (F3). Nevertheless, these covariates neither confounded the association between parental (F1) and sibling (F2) longevity and IP (F2) survival, nor that between IP (F2) and spouse (F2) longevity and their children’s (F3) survival or between longevity of aunts and uncles (F2) and the survival of IPs’ children (F3). This is in line with previous studies showing only a minor51 or no52 influence of environmental covariates on the association between parental longevity and offspring survival. It was also shown that a range of early life factors, such as farm ownership, parental literacy, and parental occupation did not affect the association between parental and offspring mortality52. We, however, cannot completely rule out that other, unobserved non-genetic familial effects may affect our results. Furthermore, using either Swedish or Dutch lifetables to determine survival percentiles was quite strict for Zeeland because of the hazardous environment46. As a result, the number of longevous persons was quite low in LINKS relative to the UPDB. Although the IPs were randomly selected, we could not completely rule out selection effects, for example related to early life mortality. However, confirmation of the F1–F2 results in the next generation F2–F3 significantly strengthens the results and allowed us to cope with the potential selection effects for IPs. In addition, a sensitivity analysis for sample size, in which we fitted all our statistical models on half of the UPDB and half of the LINKS data, provided similar results to the full sample results, indicating that our results are robust for a reduced sample size (Supplementary Figure 9).

Human Lifespan (defined as age at death) has a low heritability in the population at large1,2,3,4. Studies estimated the heritability of lifespan between 12% and 25%1,2,3 and a recent study estimated that the heritability of lifespan was even lower, ~7%, after adjustment for the lifespans of nongenetic (in-law) relatives4. Therefore lifespan-based gene mapping may not be fruitful. In addition, the genetic component of lifespan includes the heritability of early life mortality, which is mainly due to disease and external causes. Despite the low heritability and polygenic architecture26,37 of lifespan, recent genetic studies have identified31,32 and replicated53 some lifespan loci of which the rare alleles lower the risk of age-related diseases. Hence, using the lifespan trait hampers the identification of genetic loci contributing to survival into extreme ages (longevity). Longevity however, clusters strongly within families as shown by previous studies5,6,7,8,9 and robustly quantified in this study. Hence, the longevity trait is much more promising and appropriate for the identification of genetic loci contributing to survival into extreme ages and should not be confused with the lifespan trait1,12. Our results imply that to find loci that promote survival to the highest ages in the population, genetic studies should be based on long-lived cases including at least parental mortality information but preferably also mortality information of siblings and other first and second-degree relatives. The longevity threshold should include cases belonging up to the top 10% survivors, with parents belonging up to the top 15% survivors of their birth cohort and siblings belonging up to the top 10% survivors of their birth cohort. To sharpen the longevity effect, the percentile threshold applied may be made more extreme but would likely lead unnecessarily to a sample size with limited power. If our proposed longevity definition is consistently applied across studies, the comparative nature of longevity studies may improve and facilitate the discovery of novel genetic variants.

## Methods

### Ethical regulations

We complied with all relevant ethical regulations. For the Utah data (UPDB), the study was approved by the Resource for Genetic and Epidemiologic Research (RGE). For the Zeeland (LINKS) data, the study was approved by the International Institute of Social History. For this study, no informed consent needed to be obtained.

### Utah Population Database

The UPDB contains demographic and genealogical information which is linked to medical records. The data construction began in the mid-1970s with genealogy records from the archives at the Utah Family History Library and was initially based on the founding members of the Utah population, their descendants, and then subsequently all individuals living in Utah. These records contain demographic and mortality information on the pioneers of Utah (US), their parents and children, and have been linked into multigenerational pedigrees. The founding families were selected for the UPDB when at least one member had a vital event (birth, marriage, or death) on the Mormon pioneer trail or in Utah. The UPDB has been expanded to incorporate other high-quality, state-wide data sources, such as birth and death certificates, cancer records, driver license records, and census records. Currently, the UPDB contains information on more than 11 million individuals and covers a maximum of 17 generations54 (https://healthcare.utah.edu/huntsmancancerinstitute/research/updb/data/family-records.php).

### LINKing System for historical family reconstruction

The LINKS data contains demographic and genealogical information which was derived from linked vital event registers (birth, marriage, and death certificates). The data indexing began in 1995 by the “Zeeuws” archive and the results were published by way of “WieWasWie”. The data currently covers over 25 million Dutch vital event records55 (https://socialhistory.org/en/hsn/linking-system-historical-family-reconstruction-links). Data construction has been completed for the province of Zeeland and is still ongoing for the other provinces in the Netherlands. Currently LINKS Zeeland (henceforth referred to as LINKS) contains 739,453 birth, 387,102 marriage, and 641,216 death certificates which were linked together to reconstruct intergenerational pedigrees and individual life courses47. In total, the Zeeland data contains 1,930,157 persons covering a maximum of 7 generations56.

### Historical context of Utah and Zeeland

Both Utah and Zeeland were high fertility populations46,48,57, with a mean number of children of around 7 during the period of this study (1740–1952). In general, Utah was marked by healthy living conditions and Zeeland by contrast, was a much unhealthier place to live. One of the main reasons for the unhealthy living conditions in Zeeland was the lack of clean drinking water, the high prevalence of waterborne diseases and of malaria46,58,59. In Utah the quality of the drinking water was good, since water from melting snow, that was filtered running of the mountains, was used to drink48. The differences in living conditions between Utah and Zeeland were reflected by a relatively low infant and childhood mortality in Utah60 and high mortality rates for infants and children in Zeeland59, especially before 1900. Moreover, Utah was known to be a high in-migration population49 whereas there were indications that Zeeland had a low influx and outflux of migrants47.

### Study selection

All individuals in LINKS have at some point in their lives lived in Zeeland, this is because the data were constructed based on vital event records from Zeeland. Utah was first settled in 1847 and in the UPDB mortality information for ancestors of Utah associated persons are available. As a result not all persons necessarily had to live in Utah. Supplementary Table 13 shows that in our data, 97% of the IPs lived in Utah. This percentage is lower for their fathers (80%) and mothers (87%), and is an expected pattern given the historic nature of how Utah was settled. Furthermore, 70% of the siblings, 97% of the spouses, and 92% of the children lived in Utah. The majority of the persons from our sample who lived in Utah, migrated from another state in the US to Utah (87%), 12% came from Europe, and 1% from the rest of the world.

### Lifetables

We used cohort lifetables to calculate birth cohort and sex-specific survival percentiles for each individual in the UPDB and LINKS. This approach prevents against the effects of secular mortality trends over the last centuries and enables comparisons across study populations1,12. We could not use US lifetables because cohort lifetables were not available and period lifetables were only available from 1933 onward. Moreover, the US birth cohort-based central death rates were generally incomplete at the earlier cohorts (up to 1900) and proved to be of limited use for our analyses. However, for Sweden and the Netherlands, population-based cohort lifetables were available from 1751 and 1850 until 2018 respectively61,62,63,64. These lifetables contained, for each birth year and sex, an estimate of the hazard of dying between ages x and x + n (hx) based on yearly intervals (n = 1) up to 99 years of age. Conditional cumulative hazards (Hx) and survival probabilities (Sx) were derived using these hazards. In turn, we could determine the sex and birth year specific survival percentile for each person in our study. Swedish cohort lifetables date back furthest of all available lifetables and were shown to be consistent with the lifetables of multiple industrialized societies65. In addition, we ensured that the survival percentiles were calculated in the same way for the UPDB and LINKS to make a fair comparison between the survival percentiles. Hence, the Swedish cohort lifetables were used for both datasets and for the LINKS data the Dutch lifetables were used as a sensitivity analysis. Supplementary Figure 10 shows the ages at death corresponding to the top 10%, 5%, and 1% survivors for the UPDB and LINKS. This figure can be used to map the percentiles, which are based on percentile–age pairings from the Swedish lifetables, to absolute ages. For example: a top 10% female in 1750 matched an age of 76 years whereas this was 74 years for males. In 1850, a top 10% female and male matched an age of 83 years and 81 years, respectively.

### Statistical analyses

Statistical analyses were conducted using R version 3.4.166. We reported 95% confidence intervals (CIs) and considered p-values statistically significant at the 5% level (α = 0.05).

### IP survival at increasing survival percentiles of relatives

Analysis 1: To determine if (1) the association between the survival (measured as age at death) of IPs and the survival percentiles of their parents and siblings increased with increasing survival percentiles, and (2) a larger level of family aggregation, in terms of numbers of parents and siblings, was more evident at extreme survival percentiles, we investigated the association between IP survival and the number of parents and siblings reaching increasingly more extreme survival percentiles. We sequentially identified the number of parents and siblings belonging to the top x (x = 1, 2, 3, …, 60) percentiles of their birth cohorts (from here: percentiles) and we analyzed their association with the survival of the IPs for each subsequent survival percentile using a Cox proportional hazard model:

$$\lambda \left( {t_{ij}} \right) = \lambda _0\left( {t_{ij}} \right){\mathrm{exp}}\left( {{\mathbf{\beta }}{\boldsymbol{Z}}_{ij} + {\mathbf{\gamma }}{\boldsymbol{X}}_{ij}} \right)$$
(1)

where tij is the age at death for IP j in family i. λ0(tij) refers to the baseline hazard, which is left unspecified in a Cox-type model. β is the vector of regression coefficients for the main effects of interest (Z) which correspond to (1) the number of parents belonging to the top x percentile, (2) and the number of siblings belonging to the top x percentile. γ is a vector of regression coefficients for the effects of covariates and possible confounders (X) which are IPs’ religion (UPDB only), sibship size, birth cohort, sex, socio-economic status, mother’s age at birth, birth order, birth intervals, and twin birth.

### Identifying a survival threshold that demarcates longevity

Analysis 2: The previous analysis, based on the cumulative effects, does not allow us to identify a specific threshold to define longevity, since the top x percentiles were not mutually exclusive, i.e., if a person belonged to the top 1% survivors, this person also belonged to the groups of top 5% and top 10% survivors. To determine the survival percentile threshold that drove the cumulative top x percentile effects described in the previous section, we grouped IPs according to the survival of their parents and siblings for two separate analysis. More specifically, we constructed mutually exclusive groups of IPs based on having at least one parent or sibling belonging to group g (g = 1, 2, 3, …, 6): group 1 = [≥0th &  ≤1th percentile], group 2 = [≥1th &  ≤5th percentile], group 3 = [≥5th & ≤10th percentile], group 4 = [≥10th &  ≤15th percentile], group 5 = [≥15th &  ≤20th percentile], group 6 = [≥20th &  ≤100th percentile]. Group membership was defined by the most long-lived parent or sibling of the IP. Using Cox proportional hazards models (see expression (1)), we compared the effects of all groups to reference group 6, corresponding to IPs with all parents or siblings belonging to the 20th or less extreme survival percentile and multiple combinations of defining group 6 were tested. Here, the β is the vector of regression coefficients for the main effects of interest (Z) which correspond to (1) the IPs who were divided into mutually exclusive groups by their parental mortality and (2) the IPs who were independently grouped by their sibling mortality. Other parts of the expression are the same as noted in expression (1).

### Top 10% relatives and covariates in an integrated design

Analysis 3: Based on the analyses expressed in the previous section, we chose the top 10% survivors for specific follow-up analyses. Based on the results presented in the cumulative and mutually exclusive group analyses, we focused on the top 10% surviving family members because the mutually exclusive group analysis (analysis 2) indicated longevity effects for siblings beyond the top 10% and 15% for siblings and parents, respectively. Using the top 10% is consistent between the two groups and is a conservative choice. Furthermore, the cumulative analysis (analysis 1) indicated that the top 10% was a good trade-off between effect size and group size (power) within and between the UPDB and LINKS. Hence, we focused on top 10% parents and siblings in an integrated design to investigate the association between IP survival and the number of parents and siblings belonging to the top 10%. We subsequently investigated the association between the number of top 10% siblings and IP survival for IPs without top 10% parents, using Cox regression (see expression (1)). Here the β is the vector of regression coefficients for the main effects of interest (Z) which correspond to (1) the number of parents and siblings belonging to the top 10% and (2) the number of siblings belonging to the top 10% for IPs without top 10% parents. Other parts of the expression are the same as noted in expression (1).

In all Cox regression analyses, based on expression (1), we accounted for the fact that IPs were selected to have a spouse and at least one child (left truncation) by using an IP specific age at entry in the study based on the IP’s age at first child or the age at marriage, whichever was later. A similar approach was followed for the spouses of the IPs and no adjustment for left truncation was necessary for the children of the IPs, since they were not selected in any way. Moreover, we accounted for right censoring in all relatives of the IPs. We furthermore adjusted for religion (UPDB only), sibship size, birth cohort, sex, socio-economic status, mother’s age at birth, birth order, birth intervals, and twin birth since these are known to influence human survival1. Socio-economic status was constructed according to the Integrated Public Use Microdata Series (IPUMS) occupational coding scheme of 1950 (OCC1950)67. Importantly, for the sibling contribution to the cumulative percentile analysis (analysis 1), the sibling contribution to the top 10% analyses (analysis 3), and in all mutually exclusive group analyses (analysis 3), we used analytical weights when fitting the Cox models to avoid family size confounding. Adjustment was not necessary for the number of parents because this number is two by definition. However, sibship sizes vary. For example, a hypothetical IP with 4 siblings belonging to percentiles 1, 6, 8, and 30 will contribute with a weight w = 3/4 in the first analysis, based on the cumulative percentiles, when considering the top 10%. This same IP, when considering the top 5% will contribute with less weight, namely w = 1/4. In this way, each person contributed the same to the overall analysis across all percentiles. In the second analysis based on mutually exclusive groups, this same hypothetical IP would be assigned to g1, and will contribute to the analysis with a weight w = 1/4. In analysis 3, based on the top 10%, the IP will contribute with a weight of w = 3/4. In this way, we avoid a potential advantage of larger families to be represented in more extreme groups. Finally, we checked the proportional hazards and linearity assumptions in all fitted Cox models. We did not find evidence that model assumptions were violated for the main effects (parent/sibling and IP/children of IPs associations). The proportional hazards assumption was violated for some covariates. In such a case, stratification was applied for that covariate and this was mentioned in the legend of the table/figure.

### Verification of the results in a subsequent generation

Analysis 4: To verify our results regarding the top 10% parents and siblings (analysis 3) in a subsequent generation (children, F3), we investigated whether children of top 10% IPs had a survival advantage compared to children of non-longevous IPs and whether this effect is stronger if the spouse of the IP also belonged to the top 10%. We further investigated familial clustering of longevity by studying the number of top 10% aunts and uncles of the children of IPs. A Cox-type random effect model was used:

$$\lambda \left( {t_{ij}} \right) = u_i\lambda _0\left( {t_{ij}} \right){\mathrm{exp}}\left( {{\mathbf{\beta }}{\boldsymbol{Z}}_{ij} + {\mathbf{\gamma }}{\boldsymbol{X}}_{ij}} \right)$$
(2)

where tij is the age at death or the age at last follow-up for child j in family i, λ0(tij) refers to the baseline hazard, which is left unspecified, β is a vector of regression coefficients for the main effects of interest (Z) which correspond to (1) having a parent top 10% survivor in a first analysis and (2) the effect of the number of uncles/aunts (F2) top 10% in a second analysis. u > 0 refers to an unobserved random effect (frailty) shared by F3 children of a given IP. This unobserved heterogeneity shared within sibships was assumed to follow a log-normal distribution. γ contains the effect of person-specific covariates X, similar to those included in the previous analyses.

### Survival of spouses by the longevity of the index persons

Analysis 5: To investigate the survival of spouses, we applied a group approach, similar to that used above, and analyzed the groups with Cox regression. We grouped the spouses by the survival of the IPs creating 6 different groups g (g = 1, 2, 3, …, 6): group 1 = [≥0th & ≤ 1th percentile], group 2 = [≥1th & ≤ 5th percentile], group 3 = [≥5th & ≤10th percentile], group 4 = [≥10th & ≤15th percentile], group 5 = [≥15th & ≤ 20th percentile], group 6 = [≥20th & ≤100th percentile]. We compared the groups in two steps: (1) group 6 was the reference category and (2) comparing all groups with each other (post-hoc), applying a Bonferroni correction for multiple testing:

$$\lambda \left( {t_{ij}} \right) = \lambda _0\left( {t_{ij}} \right){\mathrm{exp}}\left( {{\mathbf{\beta }}{\boldsymbol{Z}}_{ij}} \right)$$
(3)

where tij is the age at death or the age at last follow-up for spouse j in family i. λ0(tij) refers to the baseline hazard, which is left unspecified in a Cox-type model. β is the regression coefficient referring to the main effects of interest (Z), which are the spouses who were divided into mutually exclusive groups by the IPs mortality.

### Code availability

The scripts containing the code for data pre-processing and data analyses can be freely downloaded at: https://git.lumc.nl/molepi/PUBLIC/Longevity_top10perc_survivors. This repository describes the main analyses done.

## Data availability

The UPDB and LINKS data that support the findings of this study are available from the UPDB and the IISG but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available upon reasonable request and with approvals of the UPDB and the IISG. The LINKS data is available upon request to Dr. Kees Mandemakers (kma@iisg.nl). The UPDB data is also available upon request and approval by the Resource for Genetic and Epidemiologic Research (RGE). More information on making this request can be obtained from one of the authors, Dr. Ken R. Smith (ken.smith@fcs.utah.edu).

Journal peer review information: Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work. Peer reviewer reports are available.

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

## References

1. 1.

van den Berg, N., Beekman, M., Smith, K. R., Janssens, A. & Slagboom, P. E. Historical demography and longevity genetics: back to the future. Ageing Res. Rev. 38, 28–39 (2017).

2. 2.

Herskind, A. M. et al. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870–1900. Hum. Genet. 97, 319–323 (1996).

3. 3.

Kaplanis, J. et al. Quantitative analysis of population-scale family trees with millions of relatives. Science 360, 171–175 (2018).

4. 4.

Ruby, J. G. et al. Estimates of the heritability of human longevity are substantially inflated due to assortative mating. Genetics 210, 1109–1124 (2018).

5. 5.

Perls, T. T. et al. Life-long sustained mortality advantage of siblings of centenarians. Proc. Natl Acad. Sci. USA 99, 8442–8447 (2002).

6. 6.

Pedersen, J. K. et al. The survival of spouses marrying into longevity-enriched families. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 72, 109–114 (2017).

7. 7.

Schoenmaker, M. et al. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur. J. Hum. Genet. 14, 79–84 (2006).

8. 8.

Ljungquist, B., Berg, S., Lanke, J., McClearn, G. E. & Pedersen, N. L. The effect of genetic factors for longevity: a comparison of identical and fraternal twins in the Swedish Twin Registry. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 53A, 441–446 (1998).

9. 9.

Berg, N. D. et al. Longevity around the turn of the 20th Century: life-long sustained survival advantage for parents of today’s nonagenarians. J. Gerontol. Ser. A 73, 1295–1302 (2018).

10. 10.

Willcox, B. J., Willcox, D. C., He, Q., Curb, J. D. & Suzuki, M. Siblings of Okinawan centenarians share lifelong mortality advantages. J. Gerontol. A Biol. Sci. Med. Sci. 61, 345–354 (2006).

11. 11.

Perls, T. T., Bubrick, E., Wager, C. G., Vijg, J. & Kruglyak, L. Siblings of centenarians live longer. Lancet 351, 1560 (1998).

12. 12.

Sebastiani, P., Nussbaum, L., Andersen, S. L., Black, M. J. & Perls, T. T. Increasing sibling relative risk of survival to older and older ages and the importance of precise definitions of “Aging,” “Life Span,” and “Longevity”. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 71, 340–346 (2016).

13. 13.

Kerber, R. A., Brien, E. O., Smith, K. R. & Cawthon, R. M. Familial excess longevity in Utah genealogies. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 56, 130–139 (2001).

14. 14.

Gudmundsson, H., Gudbjartsson, D. F. & Kong, A. Inheritance of human longevity in Iceland. Eur. J. Hum. Genet. 8, 743–749 (2000).

15. 15.

Houde, L., Tremblay, M. & Vézina, H. Intergenerational and genealogical approaches for the study of longevity in the Saguenay-Lac-St-Jean Population. Hum. Nat. 19, 70–86 (2008).

16. 16.

Kemkes-Grottenthaler, A. Parental effects on offspring longevity—evidence from 17th to 19th century reproductive histories. Ann. Hum. Biol. 31, 139–158 (2004).

17. 17.

Deluty, J. A., Atzmon, G., Crandall, J., Barzilai, N. & Milman, S. The influence of gender on inheritance of exceptional longevity. Aging 7, 412–418 (2015).

18. 18.

Andersen, S. L., Sebastiani, P., Dworkis, D. A, Feldman, L. & Perls, T. T. Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 67A, 395–405 (2012).

19. 19.

Ash, A. S. et al. Are members of long-lived families healthier than their equally long-lived peers? Evidence from the long life family study. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 70, 971–976 (2015).

20. 20.

Christensen, K., McGue, M., Petersen, I., Jeune, B. & Vaupel, J. W. Exceptional longevity does not result in excessive levels of disability. Proc. Natl Acad. Sci. USA 105, 13274–13279 (2008).

21. 21.

Evert, J., Lawler, E., Bogan, H. & Perls, T. Morbidity profiles of centenarians: survivors, delayers, and escapers. J. Gerontol. Med. Sci. 58, 232–237 (2003).

22. 22.

Vaarhorst, A. A. M. et al. Lipid metabolism in long-lived families: the Leiden Longevity Study. Age (Omaha) 33, 219–227 (2011).

23. 23.

Wijsman, C. A. et al. Familial longevity is marked by enhanced insulin sensitivity. Aging Cell. 10, 114–121 (2011).

24. 24.

Rozing, M. P. et al. Low serum free triiodothyronine levels mark familial longevity: the Leiden longevity study. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 65A, 365–368 (2010).

25. 25.

Eline Slagboom, P., van den Berg, N. & Deelen, J. Phenome and genome based studies into human ageing and longevity: an overview. Biochim. Biophys. Acta Mol. Basis Dis. 1864, 2742–2751 (2018).

26. 26.

Shadyab, A. H. & LaCroix, A. Z. Genetic factors associated with longevity: a review of recent findings. Ageing Res. Rev. 19, 1–7 (2015).

27. 27.

Deelen, J. et al. Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age. Hum. Mol. Genet. 23, 4420–4432 (2014).

28. 28.

Broer, L. et al. GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 70, 110–118 (2015).

29. 29.

Willcox, B. J. et al. FOXO3A genotype is strongly associated with human longevity. Proc. Natl Acad. Sci. USA 105, 13987–13992 (2008).

30. 30.

Flachsbart, F. et al. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc. Natl Acad. Sci. USA 106, 2700–2705 (2009).

31. 31.

Pilling, L. C. et al. Human longevity: 25 genetic loci associated in 389,166 UK biobank participants. Aging 9, 2504–2520 (2017).

32. 32.

Joshi, P. K. et al. Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity. Nat. Commun. 8, 910 (2017).

33. 33.

Sebastiani, P. et al. Four genome-wide association studies identify new extreme longevity variants. J. Gerontol. A. Biol. Sci. Med. Sci. 72, 1453–1464 (2017).

34. 34.

Sebastiani, P. et al. A family longevity selection score: ranking sibships by their longevity, size, and availability for study. Am. J. Epidemiol. 170, 1555–1562 (2009).

35. 35.

Dutta, A. et al. Longer lived parents: protective associations with cancer incidence and overall mortality. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 68, 1409–1418 (2013).

36. 36.

Terry, D. F. et al. Lower all-cause, cardiovascular, and cancer mortality in centenarians’ offspring. J. Am. Geriatr. Soc. 52, 2074–2076 (2004).

37. 37.

Christensen, K., Johnson, T. E. & Vaupel, J. W. The quest for genetic determinants of human longevity: challenges and insights. Nat. Rev. Genet. 7, 436–448 (2006).

38. 38.

Boyle, E. A., Li, Y. I. & Pritchard, J. K. An expanded view of complex traits: from polygenic to omnigenic. Cell 169, 1177–1186 (2017).

39. 39.

Joshi, P. K. et al. Variants near CHRNA3/5 and APOE have age- and sex-related effects on human lifespan. Nat. Commun. 7, 11174 (2016).

40. 40.

Gögele, M. et al. Heritability analysis of life span in a semi-isolated population followed across four centuries reveals the presence of pleiotropy between life span and reproduction. J. Gerontol. A Biol. Sci. Med. Sci. 66, 26–37 (2011).

41. 41.

Gavrilova, N. et al. Evolution, mutations, and human longevity European royal and noble families. Hum. Biol. 70, 799–804 (1998).

42. 42.

Hjelmborg, J. vB. et al. Genetic influence on human lifespan and longevity. Hum. Genet. 119, 312–321 (2006).

43. 43.

Gavrilova, N. S. & Gavrilov, L. A. When does human longevity start?: Demarcation of the boundaries for human longevity. Rejuvenation Res. 4, 115–124 (2001).

44. 44.

Jarry, V., Gagnon, A. & Bourbeau, R. Survival advantage of siblings and spouses of centenarians in 20th-century Quebec. Can. Stud. Popul. 39, 67 (2013).

45. 45.

Montesanto, A. et al. The genetic component of human longevity: analysis of the survival advantage of parents and siblings of Italian nonagenarians. Eur. J. Hum. Genet. 19, 882–886 (2011).

46. 46.

Hoogerhuis, O. W. Baren op Beveland. Vruchtbaarheid en zuigelingensterfte in Goes en omliggende dorpen gedurende de 19e eeuw. (Afd. Agrarische Geschiedenis, Wageningen Universiteit, Wageningen, 2003).

47. 47.

van den Berg, N. et al. Families in comparison: an individual-level comparison of life course and family reconstructions between population and vital event registers. Preprint at https://osf.io/preprints/socarxiv/h2w8t/ (2018).

48. 48.

Bean, L. L., Mineau, G. P. & Anderton, D. L. Fertility Change on the American Frontier: Adaptation and Innovation, Vol. 4 (University of California Press, 1990).

49. 49.

Toney, M. B., Stinner, C. M. & Kan, S. Mormon and Nonmormon migration in and out of Utah. Rev. Relig. Res. 25, 114 (1983).

50. 50.

Fogel, R. W. & Costa, D. L. A theory of technophysio evolution, with some implications for forecasting population, health care costs, and pension costs. Demography 34, 49 (1997).

51. 51.

You, D., Gu, D. & Yi, Z. Familial transmission of human longevity among the oldest-old in China. J. Appl. Gerontol. 29, 308–332 (2010).

52. 52.

Gavrilov, L. A. & Gavrilova, N. S. Predictors of exceptional longevity: effects of early-life and midlife conditions, and familial longevity. North Am. Actuar. J. 19, 174–186 (2015).

53. 53.

Timmers, P. R. H. J. et al. Genomic underpinnings of lifespan allow prediction and reveal basis in modern risks. Preprint at http://biorxiv.org/content/early/2018/07/06/363036.abstract (2018).

54. 54.

Bean, L. L., May, D. L. & Skolnick, M. The Mormon historical demography project. Hist. Methods A J. Quant. Interdiscip. Hist. 11, 45–53 (1978).

55. 55.

Mandemakers, K. LINKing System for Historical Family Reconstruction (2007).

56. 56.

Mandemakers, K. & Laan, F. LINKS Dataset Genes Germs and Resources. WieWasWie Zeeland. Civil Certificates (2017).

57. 57.

Heaton, T. B. How does religion influence fertility?: The case of Mormons. J. Sci. Study Relig. 25, 248 (1986).

58. 58.

van Poppel, F., Jonker, M. & Mandemakers, K. Differential infant and child mortality in three Dutch regions, 1812–1909. Econ. Hist. Rev. 58, 272–309 (2005).

59. 59.

van dijk, I. K. & Mandemakers, K. Like daughter. Intergenerational transmission of infant mortality clustering in Zeeland, the Netherlands, 1833–1912. Hist. Life Course Stud. 1–26 (2018).

60. 60.

Lynch, K. A., Mineau, G. P. & Anderton, D. L. Estimates of infant mortality on the Western frontier: the use of genealogical data. Hist. Methods A J. Quant. Interdiscip. Hist. 18, 155–164 (1985).

61. 61.

Wilmoth, J. R. & Shkolnikov, V. Human Mortality Database (University of California, Berkeley, USA and Max Planck Institute for Demographic Research, Germany, 2017).

62. 62.

Van Der Meulen, A. Life Tables and Survival Analysis (2012). Available at https://www.cbs.nl/en-gb/our-services/methods/statistical-methods/output/output/life-tables.

63. 63.

Carolina, T., Uijvenhoven, L. & van der Laan, J. Overlevingstafels en longitudinale analyse. CBS 1–25 (2009). Available at https://www.cbs.nl/nl-nl/onze-diensten/methoden/statistische-methoden/output/output/overlevingstafels-en-longitudinale-analyse-survival-analyse-duurmodellen.

64. 64.

Lundstrom, H. Cohort Mortality in Sweden: Mortality Statistics Since 1861 (2010). Available at https://www.scb.se/statistik/_publikationer/be0701_2010a01_br_be51br1001eng.pdf.

65. 65.

Lindahl-Jacobsen, R. et al. The male–female health-survival paradox and sex differences in cohort life expectancy in Utah, Denmark, and Sweden 1850–1910. Ann. Epidemiol. 23, 161–166 (2013).

66. 66.

R Core Team. R: A Language and Environment for Statistical Computing (2016).

67. 67.

Ruggles, S., Genadek, K., Goeken, R., Grover, J. & Sobek, M. Integrated Public Use Microdata. User’s Guide, Vol. 6 (2015).

## Acknowledgements

This research was supported by Netherlands Organization for Scientific Research [360-53-180], the Professor van Winterfonds, and the Leiden University Fund [6223/07-06-2016]. Niels van den Berg thanks Professor Ken R. Smith for hosting his stay in Utah (US) to work with the Utah Population Database. The authors also thank Dr. Joris Deelen and Dr. Thies Gehrmann for providing their input to this work as independent readers.

## Author information

### Author notes

1. These authors jointly supervised this work: Ken R. Smith, P. Eline Slagboom.

### Affiliations

1. #### Department of Biomedical Data Sciences, Section of Molecular Epidemiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands

• Niels van den Berg
• , Marian Beekman
•  & P. Eline Slagboom
2. #### Department of Family and Consumer Studies, Population Sciences, Huntsman Cancer Institute, University of Utah, 225 S. 1400 E. Rm 228, Salt Lake City, UT, USA

• Niels van den Berg
•  & Ken R. Smith
3. #### Radboud Group for Historical Demography and Family History, Radboud University, Erasmusplein 1, 6525 HT, Nijmegen, The Netherlands

• Niels van den Berg
• , Ingrid K. van Dijk
• , Rick J. Mourits
•  & Angelique A. P. O. Janssens
4. #### Department of Biomedical Data Sciences, Section of Medical Statistics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands

• Mar Rodríguez-Girondo
5. #### International Institute of Social History, Cruquiusweg 31, 1019 AT, Amsterdam, The Netherlands

• Kees Mandemakers
6. #### Max Planck Institute for Biology of Ageing, Joseph-Stelzmann-Str. 9b, 50931, Cologne, Germany

• P. Eline Slagboom

### Contributions

Niels van den Berg is the study investigator and was responsible for initiating the study, data management, data analyses, writing the first draft of the manuscript and finalizing it, and obtaining funding to visit Ken R. Smith in Utah. Angelique Janssens and P. Eline Slagboom are the study principal investigators who conceived and obtained funding for the project, which this study is a part of. Ken R. Smith is the head of the UPDB and he hosted the stay of Niels van den Berg in Utah, provided access to the UPDB, and supervised all that concerned the UPDB within this study. P. Eline Slagboom and Marian Beekman provided overall project coordination and supervision. Mar Rodriguez-Girondo provided overall statistical analyses coordination and supervision and assisted in the overall project coordination. Kees Mandemakers is the head of LINKS and provided access and support to the LINKS data. Rick Mourits provided access to documentation and conversion tables of socio-economic status coding schemes between the two databases. Ingrid van Dijk assisted with the initial family reconstruction process and assisted in working with the LINKS data.

### Competing interests

The authors declare no competing interests.

### Corresponding author

Correspondence to Niels van den Berg.